Publications by authors named "H C Tillmann"

Claim this Profile
H
Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the New Era of Expanding Non-oncology Indications: Literature Review and Expert Consensus.
Anna Fettiplace, Arie Regev, Alexandre Kiazand, Ulrike Heinzel-Pleines, Mahnoush Bahjat, Hans Tillmann

Drug Saf· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-Analysis: High anti-HBs Titers are Associated with Significantly Reduced Risk of Hepatitis B Virus Reactivation During Rituximab Treatment.
Shiva Poola, MaryKate Kratzer, Kerry Sewell, Zikun Yang, Hans L Tillmann

Aliment Pharmacol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finite Treatments for Viral Hepatitis: Is "Sustained Control" Versus Cure Acceptable for HBV?
Hans L Tillmann

Am J Gastroenterol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury.
Dina Halegoua-DeMarzio, Victor J Navarro, Ashley Davis, Jawad Ahmad, Bharathi Avula, Hans L Tillmann

Drug Saf· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review article: Recommendations for detection, assessment and management of suspected drug-induced liver injury during clinical trials in oncology patients.
Anna Fettiplace, John Marcinak, Michael Merz, Hui-Talia Zhang, Luciana Kikuchi, Hans L Tillmann

Aliment Pharmacol Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis